首页> 外文期刊>Life sciences >Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways
【24h】

Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways

机译:磷酸二酯酶抑制剂通过cAMP介导的蛋白激酶A和Epac1 / Rap1途径的活化来控制A172人胶质母细胞瘤细胞死亡

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: We investigated whether cAMP-mediated protein kinase A(PKA) and Epac1/Rap1 pathways differentially affect brain tumor cell death using 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone(rolipram), specific phosphodiesterase type IV(PDE IV) inhibitor. Main methods: A172 and U87MG human glioblastoma cells were used. Percentage of cell survival was determined by MTT assay. PKA and Epac1/Rap1 activation was determined by western blotting and pull-down assay, respectively. Cell cycle and hypodiploid cell formation were assessed by flow cytometry analysis. Key findings: Non-specific PDE inhibitors, isobutylmethylxanthine(IBMX) and theophylline reduce survival percentage of A172 and U87MG cells. The expression of PDE4A and PDE4B was detected in A172 and U87MG cells. Rolipram-treated A172 or U87MG cell survival was lower in the presence of forskolin, adenylate cyclase activator, than that in its absence. Co-treatment with rolipram and forskolin also enhanced CREB phosphorylation on serine 133 that was inhibited by H-89, PKA inhibitor and cAMP-responsive guanine nucleotide exchange factor 1(Epac1), a Rap GDP exchange factor-mediated Rap1 activity in A172 cells. When A172 cells were treated with cell-permeable dibutyryl-cAMP(dbcAMP), PKA activator or 8-(4-chloro-phenylthio)-2′-O- methyladenosine-3′,5′-cyclic monophosphate(CPT), Epac1 activator, basal level of cell death was increased and cell cycle was arrested at the phase of G2/M. Rolipram-induced A172 cell death was also increased by the co-treatment with dbcAMP or CPT, but it was inhibited by the pre-treatment with H-89. Significance: These findings demonstrate that PKA and Epac1/Rap1 pathways could cooperatively play a role in rolipram-induced brain tumor cell death. It suggests that rolipram might regulate glioblastoma cell density through dual pathways of PKA- and Epac1/Rap1-mediated cell death and cell cycle arrest.
机译:目的:我们调查了使用4-(3-环戊氧基-4-甲氧基苯基)-2-吡咯烷酮(咯利普兰),特定的磷酸二酯酶IV型(c)介导的cAMP介导的蛋白激酶A(PKA)和Epac1 / Rap1通路是否差异影响脑肿瘤细胞死亡。 PDE IV)抑制剂。主要方法:使用A172和U87MG人胶质母细胞瘤细胞。通过MTT测定法确定细胞存活百分比。 PKA和Epac1 / Rap1激活分别通过蛋白质印迹法和下拉法测定。通过流式细胞术分析评估细胞周期和二倍体细胞形成。主要发现:非特异性PDE抑制剂,异丁基甲基黄嘌呤(IBMX)和茶碱可降低A172和U87MG细胞的存活率。在A172和U87MG细胞中检测到PDE4A和PDE4B的表达。在存在福司可林,腺苷酸环化酶激活剂的情况下,经咯利普兰处理的A172或U87MG细胞的存活率低于不存在的情况。与咯利普兰和福司柯林的共同处理还增强了丝氨酸133的CREB磷酸化,该磷酸化被H-89,PKA抑制剂和cAMP响应性鸟嘌呤核苷酸交换因子1(Epac1)抑制,这是Rap GDP交换因子介导的A172细胞Rap1活性。用可渗透细胞的二丁酰-cAMP(dbcAMP),PKA激活剂或8-(4-氯-苯硫基)-2'-O-甲基腺苷-3',5'-环一磷酸(CPT),Epac1激活剂处理A172细胞,基本的细胞死亡水平增加,并且细胞周期被阻滞在G2 / M期。依利培兰与dbcAMP或CPT共同处理也增加了咯利普兰诱导的A172细胞死亡,但被H-89预处理抑制了它的死亡。意义:这些发现表明,PKA和Epac1 / Rap1途径可在咯利普兰诱导的脑肿瘤细胞死亡中协同发挥作用。这表明咯利普兰可能通过PKA和Epac1 / Rap1介导的细胞死亡和细胞周期停滞的双重途径调节胶质母细胞瘤细胞密度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号